A Phase 1 Study Evaluating CB-5083 in Subjects With Lymphoid Hematological Malignancies

Clinical trial NCT02223598 · TERMINATED

Trial details

NCT number: NCT02223598
Sponsor: Cleave Biosciences, Inc.
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Lymphoid Hematological Malignancies Relapsed and Refractory Multiple Myeloma

Start date: 2014-08-25
Primary completion: 2017-07-26
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.